SIETES :: 91969 citas

Resultados de la búsqueda por DEPENDENCIAS REFINAR BÚSQUEDA

1.

Morgan SG, Weymann D. Patterns, predictors and persistence of chronic sedative use: a population-based observational study of older adults in British Columbia, Canada. Eur J Clin Pharmacol 2017;73:1001-8. [Ref.ID 101998]

2.

Heredia Rodriguez C. New on the streets: gabapentin, a drug for nerve pain, and a new target of abuse. STAT 2017:1. [Ref.ID 101906]

3.

Guy Jr GP, Zhang K, Bohm MK, Lewis B, Young R, Murphy LB, Dowell D. Vital Signs: changes in opioid prescribing in the United States, 2006–2015. MMWR Morb Mortal Wkly Rep 2017;66:697-704. [Ref.ID 101665]

4.

Manhapra A, Rosenheck R. Opioid substitution treatment is linked to reduced risk of death in opioid use disorder. BMJ 2017;357:j1947. [Ref.ID 101635]

5.

Sordo L, Barrio G, Bravo MJ, Indave BI, Degenhardt L, Wiessing L, Ferri M, Pastor-Barriuso R. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ 2017;357:j1550. [Ref.ID 101634]

6.

Becker WC, Fiellin DA. Abuse-deterrent opioid formulations - Putting the potential benefits into perspective. N Engl J Med 2017;376:2103-5. [Ref.ID 101625]

7.

The Data Team. Millennials are less keen than previous generations on illicit drugs. They are taking up painkillers instead. The Economist 2017:1. [Ref.ID 101607]

8.

Volkow ND, Koroshetz W. Lack of evidence for benefit from long term use of opioids analgesics for patients with neuropathy.. JAMA Neurology 0:1-2. [Ref.ID 101594]

9.

Hoffman EM, Watson JC, St Sauver J, Staff NP, Klein CJ. Association of long-term opioid therapy with functional status, adverse outcomes, and mortality among patients with polyneuropathy. JAMA Neurology 2017;74:773-9. [Ref.ID 101593]

10.

Bradford AC, Bradford WD. Medical marijuana laws may be associated with a decline in the number of prescriptions for Medicaid enrollees. Health Affairs 2017;36:1 de mayo. [Ref.ID 101570]

11.

Anónimo. Congressional representatives warn WHO of Purdue Pharma’s global push. DIA Daily 2017:3. [Ref.ID 101563]

12.

Anónimo. Cherokee nation sues drug distributors, pharmacies for spreading addictive opioids medications. DIA Daily 2017:1. [Ref.ID 101538]

13.

Soyka M. Treatment of benzodiazepine dependence. N Engl J Med 2017;376:1147-57. [Ref.ID 101503]

14.

Karaca-Mandic P, Meara E, Morden NE. The growing problem of co-treatment with opioids and benzodiazepines. BMJ 2017;356:j1224. [Ref.ID 101495]

15.

Sun EC, Dixit A, Humphreys K, Darnall BD, Baker LC, Mackey S. Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis. BMJ 2017;356:j760. [Ref.ID 101494]

16.

Nielsen S, Larance B, Lintzeris N. Opioid agonist treatment for patients with dependence on prescriptions opioids. JAMA 2017;317:967-8. [Ref.ID 101470]

17.

Henche Ruiz AI. El auge de la analgesia opioide. Problemas relacionados con su uso a largo plazo. Boletín Farmacoterapéutico de Castilla-La Mancha 2016;17:1-6. [Ref.ID 101039]

18.

Anónimo. FDA drops boxed warning on smoking cessation drug. DIA Daily 2016:1. [Ref.ID 101000]

19.

Anónimo. Psilocybin may reduce depression and anxiety in some cancer patients, studies suggest. DIA Daily 2016:1. [Ref.ID 100992]

20.

Gaither JR, Leventhal JM, Ryan SA, et al.. National trends in hospitalizations for opioid poisonings among children and adolescents, 1997 to 2012. JAMA Pediatrics 2016:31 de octubre. [Ref.ID 100870]